Novartis AG Registered Shares NOVN
News
Novartis Gets Positive Test Results for Cholesterol Drug
Novartis Confirms Offer for Diagnostic Arm From Siemens Healthineers
Novartis says FDA gives accelerated approval for kidney-disease treatment
Novartis Says FDA Gives Accelerated Approval for Kidney-Disease Treatment
Novartis's Scemblix Granted FDA Priority Review
Trending: Novartis Raises Profit Guidance as It Prepares for Patent Expirations
Novartis lifts guidance again as demand climbs for top drugs
Novartis Raises Profit Guidance as Key Drugs Boost Sales — Update
Novartis Raises Profit Guidance as Key Drugs Boost Sales
Novartis On Pace for Record High Close — Data Talk
Novartis on Track for Record High Close — Data Talk
Carisma Therapeutics Notifies Novartis Pharmaceuticals of Terminated Manufacturing, Supply Agreement
Cytokinetics CEO Says Board Would Have Backed Actionable Buyout
Novartis Gets FDA Breakthrough Therapy Designation for Scemblix
Novartis to Buy Mariana Oncology for Up to $1.75 Billion in Boost to Radioligand Therapy Business
Novartis to pay up to $1.75 billion for U.S. cancer-focused biotech
Novartis, Medicines for Malaria Say Treatment for Babies Shows Efficacy
Novartis Gets FDA Approval for Lutathera in Pediatric Treatment
Trending: Novartis Shares Climb on Guidance Lift